Recent findings from the UNC Gillings School of Global Public Health underscore the robust efficacy and longevity of COVID-19 vaccines as of 2025. The data reveals that recipients of these vaccines continue to enjoy strong, durable protection against the virus, significantly reducing the risk of severe illness and hospitalization. This evidence is crucial in the global effort to manage COVID-19, emphasizing the importance of vaccination programs worldwide. By demonstrating sustained immunity, these findings reassure both individuals and public health policymakers of the vaccines’ enduring effectiveness. As vaccine hesitancy remains an issue, this data could play a pivotal role in encouraging uptake by highlighting the long-term benefits. Moreover, the research underscores the vaccines’ potential to adapt to emerging variants, maintaining a frontline defense against the evolving threat of COVID-19.
UNC Gillings School of Global Public HealthNew data shows Tesla’s UK Sales Drop in February but Still Surpass BYD
March 5, 2026
In February, Tesla experienced a significant downturn in its UK sales, according to the latest data from New Automotive. Despite the plunge, Tesla managed to